Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2211-2220 of 2762 for

Edit search filters
  1. Olmsted County Healthy Skin Study

    Rochester, MN

  2. Adrenocortical Carcinoma in Children

    Rochester, MN

  3. Genomic Assessment in Patients with Untreated Advanced Biliary Cancers and Germ Cell Tumors

  4. Exploring Duodenal Biopsies as a Biomarker of Pancreatic Cancer

    Rochester, MN

  5. Profiling of Lung Cancer for Identification of Treatment Targets and Strategies

    Jacksonville, FL

  6. Return of Results of Pharmacogenomic Testing for Genes Involved in Metabolism of 5FU and Capecitibine

    Rochester, MN

  7. Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

    Rochester, MN

  8. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  9. Development of Potential COVID-19 Vaccine and Serological Assay

    Rochester, MN

  10. Biomarkers to Predict for and Monitor Response to PD-1/PD-L1 Inhibitors

    Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer